Tethys enlists docs to change diabetes' course

May 26, 2011

The future of Tethys Bioscience Inc.’s predictive diabetes test may rely on places like Burlington, Iowa, and small-town family practitioners like Dr. Michael AbouAssaly.

Tethys’ simple blood test, which scores the risk of pre-diabetics getting full-blown type 2 diabetes within five years, hit the market in early 2009 to scientific applause. The test, called PreDx (sounds like “predicts”), could help doctors concentrate on their highest-risk patients and change the course of the disease, according to Emeryville-based Tethys.

Read more >>>>